Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 31 min ago
Peer-reviewedCC BY-NC-ND 4.0Trials

Efficacy and safety of FXI antibody cenvacibart compared with aspirin for venous thromboprophylaxis in patients after total knee arthroplasty (ROXI-ASPEN): study protocol for a phase 3, double-blinded, randomized trial

Related

  1. Aspirin-Based Thromboprophylaxis Versus Anticoagulant Regimens After Total Hip or Knee Arthroplasty: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Hasan Al Chalabi, Omar Amro, Amy Gordon +1
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Efficacy of a smartphone digital therapeutic (re-R) for post-total knee arthroplasty rehabilitation: study protocol for a single-center randomized controlled trial in the Republic of Korea
    Sung-Yeon Oh, Yeon-Gyo Nam
    TrialsPeer-reviewedCC BY-NC-ND 4.0Surgery & anaesthesiaCrossref
  3. Efficacy and safety of antibody-drug conjugates in pretreated HER2-positive advanced breast cancer: a network meta-analysis of randomized controlled trials
    Fen Liu, Yong Pan, Jinlan Li +2
    Frontiers in pharmacologyPeer-reviewedCC BYFull textPharmacology & toxicologyEurope PMC
  4. Safety and efficacy of lacnotuzumab, a colony-stimulating factor 1 antibody for the treatment of tenosynovial giant cell tumors: a randomized phase II trial
    Edward Cheng, Ursula Schramm, Alireza Mirzaei +22
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref
  5. Efficacy of real-time feedback exercise therapy in patients following total hip arthroplasty: a pilot cluster-randomized controlled trial
    Klaus Widhalm, Lukas Berger-Maul, Harald Penasso +5
    BMC Musculoskeletal DisordersPeer-reviewedCC BY-NC-ND 4.0Full textSurgery & anaesthesiaPMC
BibTeX
@article{kithcart2026efficacy,
  title = {{Efficacy and safety of FXI antibody cenvacibart compared with aspirin for venous thromboprophylaxis in patients after total knee arthroplasty (ROXI-ASPEN): study protocol for a phase 3, double-blinded, randomized trial}},
  author = {Aaron P. Kithcart and Margaret Onisko and Wanxue Zou and Siyu Li and José G. Raya and David E. Gutstein and Chase W. Smitterberg and ROXI-ASPEN Steering Committee and Michael A. Mont},
  journal = {Trials},
  year = {2026},
  month = oct,
  doi = {10.1186/s13063-026-10054-5},
  url = {https://link.springer.com/article/10.1186/s13063-026-10054-5},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Efficacy and safety of FXI antibody cenvacibart compared with aspirin for venous thromboprophylaxis in patients after total knee arthroplasty (ROXI-ASPEN): study protocol for a phase 3, double-blinded, randomized trial
AU  - Aaron P. Kithcart
AU  - Margaret Onisko
AU  - Wanxue Zou
AU  - Siyu Li
AU  - José G. Raya
AU  - David E. Gutstein
AU  - Chase W. Smitterberg
AU  - ROXI-ASPEN Steering Committee
AU  - Michael A. Mont
PY  - 2026
DA  - 2026/10/30
JO  - Trials
DO  - 10.1186/s13063-026-10054-5
UR  - https://link.springer.com/article/10.1186/s13063-026-10054-5
SN  - 1745-6215
ER  -